Cerebrolysin for speech recovery after stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether a medicine called Cerebrolysin can help improve speech in people who have trouble speaking after a stroke. It is for Korean speakers who had their first stroke within the last month.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a stroke for the first time that affected the left side of your brain.
- You have trouble speaking fluently (non-fluent aphasia), confirmed by a language test.
- You are a native Korean speaker between 19 and 90 years old.
- You are right-handed.
- You are within one month of your stroke.
- You are not allergic to Cerebrolysin and do not have serious other health problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether stimulating the cerebellum can improve word-finding and language skills in people with aphasia after a left-sided stroke. It’s meant for people who are months past their stroke and still have naming difficulties.
This study looks at how the brain rewires itself after a stroke that causes aphasia (language problems). It uses brain scans to understand changes in brain networks, which may help improve recovery treatments.
This study tests a drug called Cerebrolysin, which may help protect the brain after a bleeding stroke. It is given within 6 hours of the stroke, and researchers will check if it is safe and helps improve recovery.
This study tests whether repeated sessions of transcranial magnetic stimulation (a non-invasive brain stimulation therapy) can help people who recently had a stroke and are having trouble speaking (aphasia). It is for patients who were hospitalized within the last 7 days and are right-handed.
This study uses brain scans to understand how the brain controls speech in people who have had a cerebellar stroke. It is looking for both stroke survivors and healthy volunteers to compare.
This trial tests whether targeted mild brain stimulation (tDCS) can improve speech therapy results for people with long-lasting (chronic) aphasia after a stroke. It may help strengthen naming and communication when added to standard speech-language treatment.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.